OUR TEAM
Dr. Marc Mayberg M.D.
neurosurgeon, CEO, FOUNDER, DIRECTOR
Marc R. Mayberg, M.D., is Clinical Professor in the Department of Neurological Surgery at the University of Washington, with a specialty practice in pituitary and skull base tumors. He is a graduate of Harvard University and the Mayo Medical School, and completed his residency in neurosurgery at Massachusetts General Hospital. After completing a Van Wagenen fellowship at the National Hospital for Nervous Diseases in London in 1985, Dr. Mayberg joined the faculty of the Department of Neurological Surgery at the University of Washington, where he was Professor and Chief of the UWMC hospital neurosurgical service. In 1998, he was appointed Chairman Neurological Surgery at The Cleveland Clinic, before returning to Seattle in 2004 to co-found the Swedish Neuroscience Institute.
The author of more than 250 scientific papers and book chapters and three textbooks, Dr. Mayberg has served on the editorial boards for numerous peer-reviewed journals including Journal of Neurosurgery (Chairman), Stroke, Neurosurgery, Journal of Surgical Research, and was Co-Editor of Neurosurgery Clinics of North America. He has held numerous national leadership positions, including President of the Congress of Neurological Surgery, Vice-Chair of the American Board of Neurological Surgery and Chair of the Stroke Council of the American Heart Association.
Dr. Gary M. Myles, Ph.D.
IP Counsel, FoundeR, DIRECTOR
As a biotechnology patent attorney, Gary drafts and prosecutes patent applications for a broad range of life sciences inventions and develops intellectual property strategies for university, non-profit, start-up, and mid- and large-cap bio/pharma clients in the life sciences and agricultural industries. Gary also formulates freedom-to-operate, non-infringement and invalidity opinions and performs intellectual property due diligence reviews. His areas of technological expertise include molecular and cell biology, biochemistry, virology, cell biology, immunology, nanotechnology, and personalized medicine.
Gary's scientific experience includes post-doctoral research on the molecular mechanisms of signal transduction at the Fred Hutchinson Cancer Research Center in Seattle and graduate research at the University of North Carolina in Chapel Hill. His Ph.D. in biochemistry and biophysics was awarded for his research on "Structure-Function Studies on Uvra: An Escherichia coli DNA Repair Protein," which was performed in the laboratory of Aziz Sancar, recipient of 2015 Nobel Prize in Chemistry. Prior to attending graduate school, Dr. Myles worked in the Hepatitis/HIV division at Abbott Laboratories, took graduate coursework in chemical engineering at the University of Michigan in Ann Arbor, and obtained a B.S. in biochemistry from the University of Illinois in Urbana/Champaign.
Gary is an adjunct professor of law at Seattle University, where he teaches Biotechnology and the Law, and is an adjunct professor and Law, Technology, and Arts Fellow at the University of Washington, where he teaches Advanced Patent Law. Gary obtained his J.D. from the University of Washington and is admitted to the Washington State Bar, District Court for the Western District of Washington, and United States Patent and Trademark Office.
Hans LundiN
CFO, Founder, DIRECTOR
Hans has over 20 years of experience in entrepreneurial and venture capital financial management. Hans is currently the CFO for Specifica. His experience includes financial operations, forecasting, deal negotiation, M&A, interim CFO consulting, and board participation. Hans has worked with biotechnology, healthcare IT, and healthcare service companies that are private equity and venture capital-backed.
Executive Chairman, Founder, DIRECTOR
President, IBH, INC. Joe has been involved in healthcare new company formation for the past 45 years as corporate counsel for a public Healthcare company, founder of a healthcare services company and he has been a corporate VC and a VC. He has over $1.0BB of VC and finance-related experience. Joe retired on 12/31/2020 from Point B Capital ( a Corporate Venture Capital fund) and is still Active with IBH, Inc. (a venture services management company). He is on the board of the Technology Alliance, Chairman of the PNW Chapter of Breakthrough T1D (JDRF), and he is Executive Chair of PatchClamp MedTech, Inc.
Joe Piper
Adam SMITH
CTO, DIRECTOR
Adam Smith is a managing engineer at Product Creation Studio (PCS), an award-wining design firm based in Seattle, Washington. Adam has vast experience in the development of Minimally Invasive Devices and will serve as PatchClamp’s CTO. PCS designs a wide range of Consumer and Medical products for clients around the world. From graphic design to mechanical engineering, the company offers complete, turnkey development solutions, supported by market research, user testing and focus groups.
Daren Nitz
Corporate Counsel
Daren Nitz has over 30 years experience representing entrepreneurs, public and private companies, underwriters, and venture investors in private and public equity, debt and convertible securities offerings in emerging and established businesses. Mr. Nitz assists clients on a wide variety of corporate matters, including venture formation, equity and debt financing, corporate governance and planning, strategic alliances, and mergers and acquisitions, as well as acting as outside general counsel.